"I am delighted that Dr Currie is joining our Scientific Advisory Board,” said Tony Keating, CEO and Managing Director of ResApp Health. “His extensive experience in medical research at leading US hospitals will provide us with invaluable clinical expertise as we move forward with paediatric and adult clinical studies this US winter."
In my view, this is almost worth being tagged "price sensitive".
Ann: Dr Philip Currie Joins ResApp's Scientific Advisory Board, page-2
-
- There are more pages in this discussion • 179 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)